Korro Bio, Inc.
KRRO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | – | – | 72.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,890.1% | – | – | -569.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,680.4% | – | – | -602% |
| EPS Diluted | -9.37 | -53.08 | -227.42 | -4.94 |
| % Growth | 82.3% | 76.7% | -4,503.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |